Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiang Shan

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
Hepatology (Baltimore, Md.)|April 12, 2011
Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virusZong-Gen Peng, Zhi-Yun Zhao, Yan-Ping Li, et al.
The Journal of Clinical Investigation|November 26, 2024
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.
Science Immunology|May 1, 2026
Citraconate preserves T cell stemness and antitumor immunityWenhui Li, Minmin Ge, Ziyi Luo, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
Hepatology (Baltimore, Md.)|April 12, 2011
Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virusZong-Gen Peng, Zhi-Yun Zhao, Yan-Ping Li, et al.
The Journal of Clinical Investigation|November 26, 2024
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.
Science Immunology|May 1, 2026
Citraconate preserves T cell stemness and antitumor immunityWenhui Li, Minmin Ge, Ziyi Luo, et al.
Pageof 16